Evidence map›Paper›PMID 18046429›Full record

ReviewGene therapy2008

Toward 'SMART' stem cells.

T Cheng

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Gene therapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Biomechanical cues as master regulators of hematopoietic stem cell fate.Cellular and molecular life sciences : CMLS · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

1 author.

T ChengDepartment of Radiation Oncology, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213-1863, USA. chengt@upmc.edu

Funding

Stem Cell Efficiency Regulated by CDK InhibitorsR01HL070561 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHENG, TAO · 2001 to 2011
$3.3M
Negative Effects of Irradiated Hosts on Transplanted Hematopoietic Stem CellsR01AI080424 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHENG, TAO · 2008 to 2012
$1.9M
NHLBI NIH HHS HL70561NHLBI NIH HHS R01 HL070561NIAID NIH HHS R01 AI080424
6 · The paper itself

Abstract

Stem cell research is at the heart of regenerative medicine, which holds great promise for the treatment of many devastating disorders. However, in addition to hurdles posed by well-publicized ethical issues, this emerging field presents many biological challenges. What is a stem cell? How are embryonic stem cells different from adult stem cells? What are the physiological bases for therapeutically acceptable stem cells? In this editorial review, I will briefly discuss these superficially simple but actually rather complex issues that surround this fascinating cell type. The goal of this special issue on stem cells in Gene Therapy is to review some fundamental and critical aspects of current stem cell research that have translational potential.

Indexed as

Cell LineageGenetic TherapyHumansResearchStem CellsStem Cell TransplantationTissue Engineering

Identifiers

PMID18046429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.